Stocks Hitting 52-Week Highs

shares rose 8.30 percent to reach a new 52-week high of $32.23 as the company reported better-than-expected results for the first quarter and issued a strong revenue forecast for the year.

shares reached a new 52-week high of $236.409 as the company reported upbeat results for its first quarter and raised its guidance for the year.

shares gained 14.23 percent to touch a new 52-week high of $8.08 as the company reported the FDA approval for Probuphine.

shares gained 13.73 percent to touch a new 52-week high of $107.57 as the company agreed to be acquired by

for $4.2 billion.